Electronic Implant Uses Electricity to Lower Blood Sugar in Diabetic Mice

Researchers have developed a tiny electronic implant that uses electricity to lower blood sugar by converting excess glucose into a substance excreted via urine, showing promise in diabetic mice. The experimental device offers a potential new approach for managing type 2 diabetes, particularly in patients with excess weight. Developed by ETH Zurich scientists, the implant uses a gold and platinum catalyst to trigger a chemical reaction, converting glucose into gluconate for kidney removal. It operates via a closed-loop system with a continuous glucose monitor, activating wirelessly through a smartphone when sugar levels rise and switching off automatically. In tests, diabetic mice achieved restored glucose balance, weight loss, and lower triglycerides over six weeks without tissue damage. However, the implant remains experimental, untested in humans, and requires clinical trials to confirm safety and effectiveness.